Table 4.
Ref. | [144] | [145] | [150] |
Basal Media | IMDM | IMDM | 17.7 g/L IDMD |
Supplemented With | 17.91 ng bovine FGF/mL | 5 mg/mL human serum albumin | 5 mM l-glutamine |
2.80 mg/mL human albumin | 100 μg/mL human Ex-Cyte lipoprotein | 3.024 g/L sodium bicarbonate | |
27. 65 µM hydrocortisone | 2 μg/mL saturated human transferrin | 10 mg/L rh insulin | |
1.18% SITE (S4920; containing 0.5 µg/mL sodium selenite, 1.0 mg/mL bovine insulin, 0.55 mg/mL human transferrin, 0.2 mg/mL ethanolamine; 100-fold concentrate) |
10 μg/mL rh insulin | 10 mg/L rh transferrin | |
1.0% 100 × MEM vitamins | 4 g/L rh serum albumin | ||
0.89% MEM essential amino acids | 55 μM β-mercaptoethanol | ||
0.4% MEM nonessential amino acids | 0.1% chemically defined lipid concentrate | ||
1 mM sodium pyruvate | 2% MEM essential amino acids solution | ||
1 mM GlutaMAX-I supplement | 1% MEM non-essential amino acid solution | ||
10 μg/mL folic acid | 1% Vitamins solution | ||
10 μM ascorbic acid 2-phosphate | 0.1% trace elements solution | ||
1.0 μg/mL Biotin | 50 μg/L hydrocortisone | ||
1.36 μg/mL vitamin B12 mix | 50 mg/L l-ascorbic acid-2-phosphate | ||
500fold diluted trace element mix | 5 mg/L rh fibronectin | ||
4 × 10−8 M FeSO4 | 5 μg/L progesterone | ||
10 μg/mL nucleoside mix (ribonucleosides, 2′-deoxyribo-nucleosides, uridine, and thymidine) |
10 mg/L putrescine | ||
2 mg/L serotonin | |||
10 ng/mL rh EGF | |||
1.0% antibiotic/antimycotic | 10 ng/mL rh basic FGF | ||
10–20 ng/mL rh PDGF ββ homodimer or 10−5 to 10−6 M 5-hydroxytryptamine |
10 ng/mL rh PDGF | ||
10 ng/mL rh IGF |
(Abbreviations: EGF—epidermal growth factor, FGF—fibroblast growth factor, rh—recombinant human, IGF—insulin-like growth factor, IMDM—Iscove’s modified Dulbecco’s medium, MEM—minimum essential media, PDGF—platelet-derived growth factor).